Vulnerability · CVE-2023-54317
In the Linux kernel, the following vulnerability has been resolved: dm flakey: don't corrupt the zero page When we need to zero some range on a block device, the funct…
Published Dec 30, 2025 · catalog updated Oct 15, 2026 · the affected product
Check if you run it
No confirmed exploitation is on record for CVE-2023-54317. EPSS is 0.15%. Act only if a listed version of the affected product is installed.
Gaps on this record
- No plain product name is stored. The page cannot tell you which product to check.
- No version range is stored. A customer cannot check an installed version against this record.
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- High7.8
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.15%
- Remediation
- Not established
- Affected products
- See sources for product scope
In the Linux kernel, the following vulnerability has been resolved: dm flakey: don't corrupt the zero page When we need to zero some range on a block device, the function __blkdev_issue_zero_pages submits a write bio with the bio vector pointing to the zero page. If we use dm-flakey with corrupt bio writes option, it will corrupt the content of the zero page which results in crashes of various userspace programs. Glibc assumes that memory returned by mmap is zeroed and it uses it for calloc implementation; if the newly mapped memory is not zeroed, calloc will return non-zeroed memory. Fix this bug by testing if the page is equal to ZERO_PAGE(0) and avoiding the corruption in this case.
No affected version ranges are stored yet. Use the vendor advisory before you decide this record does not apply.
How to fix CVE-2023-54317
Recommended remediation
No required-action text, fix commit, or clear fixed-version range is stored yet.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2023-54317. EPSS is 0.15%. Act only if a listed version of the affected product is installed.
Which versions are affected?
Affected version ranges are not on this record. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
No weakness class is stored. EPSS 0.15%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Dec 30, 2025 · NIST NVD
Detected
In the Linux kernel, the following vulnerability has been resolved: dm flakey: don't corrupt the zero page When we need to zero some range on a block device, the function __blkdev_issue_zero_pages submits a write bio with the bio vector pointing to the zero page. If we use dm-flakey with corrupt bio writes option, it will corrupt the content of the zero page which results in crashes of various use
Oct 15, 2026 · NIST NVD
Updated
In the Linux kernel, the following vulnerability has been resolved: dm flakey: don't corrupt the zero page When we need to zero some range on a block device, the function __blkdev_issue_zero_pages submits a write bio with the bio vector pointing to the zero page. If we use dm-flakey with corrupt bio writes option, it will corrupt the content of the zero page which results in crashes of various use
Sources
- CVE.orgVulnerability recordCVE-2023-54317
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2023-54317
30-day exploitation probability 0.15%
first.org - NIST NVDVulnerability recordCVE-2023-54317
In the Linux kernel, the following vulnerability has been resolved: dm flakey: don't corrupt the zero page When we need to zero some range on a block device, the function __blkdev_issue_zero_pages submits a write bio with the bio vector pointing to the zero page. If we use dm-f
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 21, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.